Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.909,33
0,19%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Axonics Inc (AXNX) Axonics Inc (AXNX) Notizie

AXNX

Axonics (AXNX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AXNX
DataOraFonteTitoloSimboloCompagnia
30/04/202422:01Business WireAxonics Reports First Quarter 2024 Financial ResultsNASDAQ:AXNXAxonics Inc
24/04/202412:30PR Newswire (US)Boston Scientific Announces Results for First Quarter 2024NASDAQ:AXNXAxonics Inc
22/03/202421:01Business WireAxonics Stockholders Approve Merger Agreement with Boston ScientificNASDAQ:AXNXAxonics Inc
21/03/202421:54Business WireAxonics Provides Update on Inter Partes Review ProceedingsNASDAQ:AXNXAxonics Inc
14/03/202411:00Business WireAxonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation SystemNASDAQ:AXNXAxonics Inc
07/03/202423:24Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AXNXAxonics Inc
29/02/202422:01Business WireAxonics Responds to ITC Action by MedtronicNASDAQ:AXNXAxonics Inc
28/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXNXAxonics Inc
28/02/202422:01Business WireAxonics Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
22/02/202414:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:AXNXAxonics Inc
03/02/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
31/01/202412:30PR Newswire (US)Boston Scientific Announces Results for Fourth Quarter and Full Year 2023NASDAQ:AXNXAxonics Inc
10/01/202421:07PR Newswire (US)Kuehn Law Encourages AMAM, HARP, AXNX, and CPE Investors to Contact Law FirmNASDAQ:AXNXAxonics Inc
08/01/202423:19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AXNXAxonics Inc
08/01/202422:55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.NASDAQ:AXNXAxonics Inc
08/01/202417:36Dow Jones NewsAxonics Shares Climb 20% After Acquisition by Boston ScientificNASDAQ:AXNXAxonics Inc
08/01/202413:41Dow Jones NewsBoston Scientific To Acquire Axonics For About $3.7 BillionNASDAQ:AXNXAxonics Inc
08/01/202413:00PR Newswire (US)Boston Scientific Announces Agreement to Acquire Axonics, Inc.NASDAQ:AXNXAxonics Inc
08/01/202413:00Business WireAxonics Announces Definitive Agreement to be Acquired by Boston ScientificNASDAQ:AXNXAxonics Inc
08/01/202413:00Business WireAxonics Reports Preliminary 4Q23 and Fiscal Year 2023 RevenueNASDAQ:AXNXAxonics Inc
27/12/202322:01Business WireAxonics to Present at the J.P. Morgan Healthcare ConferenceNASDAQ:AXNXAxonics Inc
26/12/202319:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXNXAxonics Inc
06/11/202318:00GlobeNewswire Inc.Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual DisabilitiesNASDAQ:AXNXAxonics Inc
01/11/202311:00Business WireAxonics to Participate in November Investor ConferencesNASDAQ:AXNXAxonics Inc
30/10/202321:01Business WireAxonics Reports Third Quarter 2023 Financial ResultsNASDAQ:AXNXAxonics Inc
07/10/202302:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXNXAxonics Inc
04/10/202301:32Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AXNXAxonics Inc
02/10/202312:00Business WireAxonics to Report Third Quarter 2023 Financial Results on October 30NASDAQ:AXNXAxonics Inc
25/08/202312:00Business WireAxonics to Participate in September Investor ConferencesNASDAQ:AXNXAxonics Inc
21/08/202312:00Business WireAxonics Announces CFO Retirement and Appoints SuccessorNASDAQ:AXNXAxonics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AXNX

La tua Cronologia

ASX
ARF
Arena REIT
HITB
BKXBTC
Bankex
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network